Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Lemaitre Vascular (LMAT)

Lemaitre Vascular (LMAT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
91.61 -0.15 (-0.16%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 91.61 unch (unch) 16:01 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
90.23
Day High
92.05
Open 91.07
Previous Close 91.76 91.76
Volume 106,900 106,900
Avg Vol 199,505 199,505
Stochastic %K 95.55% 95.55%
Weighted Alpha +27.79 +27.79
5-Day Change +5.33 (+6.18%) +5.33 (+6.18%)
52-Week Range 64.27 - 109.58 64.27 - 109.58
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,073,225
  • Shares Outstanding, K 22,594
  • Annual Sales, $ 219,860 K
  • Annual Income, $ 44,040 K
  • EBIT $ 52 M
  • EBITDA $ 62 M
  • 60-Month Beta 0.89
  • Price/Sales 9.20
  • Price/Cash Flow 37.49
  • Price/Book 5.97

Options Overview Details

View History
  • Implied Volatility 51.59% ( +3.14%)
  • Historical Volatility 40.10%
  • IV Percentile 96%
  • IV Rank 91.78%
  • IV High 53.92% on 04/21/25
  • IV Low 25.62% on 05/22/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 143
  • Open Int (30-Day) 94

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.50
  • Number of Estimates 5
  • High Estimate 0.52
  • Low Estimate 0.50
  • Prior Year 0.44
  • Growth Rate Est. (year over year) +13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.42 +28.27%
on 04/07/25
Period Open: 85.08
92.41 -0.87%
on 04/24/25
+6.53 (+7.68%)
since 03/25/25
3-Month
71.42 +28.27%
on 04/07/25
Period Open: 96.89
105.55 -13.21%
on 02/26/25
-5.28 (-5.45%)
since 01/24/25
52-Week
64.27 +42.54%
on 04/26/24
Period Open: 62.99
109.58 -16.40%
on 11/25/24
+28.62 (+45.44%)
since 04/25/24

Most Recent Stories

More News
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

LMAT : 91.61 (-0.16%)
TFX : 135.21 (-0.33%)
IART : 16.81 (+0.66%)
ISRG : 514.59 (+1.27%)
3 Healthcare Stocks Facing Headwinds

3 Healthcare Stocks Facing Headwinds

STE : 225.00 (-0.60%)
LMAT : 91.61 (-0.16%)
MASI : 163.74 (+0.68%)
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4

Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4

TFX : 135.21 (-0.33%)
LMAT : 91.61 (-0.16%)
IART : 16.81 (+0.66%)
ISRG : 514.59 (+1.27%)
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025

LMAT : 91.61 (-0.16%)
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference

LMAT : 91.61 (-0.16%)
2 Reasons to Avoid LMAT and 1 Stock to Buy Instead

2 Reasons to Avoid LMAT and 1 Stock to Buy Instead

LMAT : 91.61 (-0.16%)
WAB : 184.03 (-0.73%)
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

TFX : 135.21 (-0.33%)
LMAT : 91.61 (-0.16%)
IART : 16.81 (+0.66%)
ISRG : 514.59 (+1.27%)
Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)

Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)

LMAT : 91.61 (-0.16%)
TFX : 135.21 (-0.33%)
IART : 16.81 (+0.66%)
ISRG : 514.59 (+1.27%)
Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors

POCI : 4.29 (+0.94%)
LMAT : 91.61 (-0.16%)
3 Best Earnings Growth Stocks to Buy in March: CAKE, LMAT, HURN

To determine earnings, analyze revenues minus production costs. Earnings growth is crucial for all companies as survival hinges on profitability. Earnings are also considered the most important variable...

CAKE : 50.15 (-0.65%)
LMAT : 91.61 (-0.16%)
HURN : 134.14 (-0.25%)
Ensign Group Expands Healthcare Portfolio With Key Acquisitions

The Ensign Group, Inc. ENSG recently purchased the real estate and operations of a healthcare campus in Oregon, one skilled nursing facility and another senior living unit in Alaska, a skilled nursing...

JAZZ : 110.80 (+1.67%)
LMAT : 91.61 (-0.16%)
PCRX : 25.72 (-1.08%)
ENSG : 126.04 (+0.94%)
Best Momentum Stocks to Buy for March 4th

Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, March 4th:Option Care Health, Inc. OPCH: This home and alternate site infusion services company has...

OPCH : 32.90 (+2.24%)
LMAT : 91.61 (-0.16%)
LeMaitre to Participate at Upcoming Investor Conferences in March

LMAT : 91.61 (-0.16%)
LeMaitre: Q4 Earnings Snapshot

LeMaitre: Q4 Earnings Snapshot

LMAT : 91.61 (-0.16%)
LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%

LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%

LMAT : 91.61 (-0.16%)
LeMaitre Q4 2024 Financial Results

LMAT : 91.61 (-0.16%)
What To Expect From LeMaitre’s (LMAT) Q4 Earnings

What To Expect From LeMaitre’s (LMAT) Q4 Earnings

LMAT : 91.61 (-0.16%)
IART : 16.81 (+0.66%)
ISRG : 514.59 (+1.27%)
LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025

LMAT : 91.61 (-0.16%)
LeMaitre Vascular Prices $150 Million Convertible Senior Notes

LMAT : 91.61 (-0.16%)
LeMaitre Vascular, Inc. Announces Proposed $150 Million Offering of Convertible Senior Notes Due 2030

LeMaitre Vascular plans to offer $150 million in Convertible Senior Notes due 2030 to qualified institutional buyers.Quiver AI SummaryLeMaitre Vascular, Inc. announced its plan to offer up to $150 million...

LMAT : 91.61 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and...

See More

Key Turning Points

3rd Resistance Point 94.18
2nd Resistance Point 93.12
1st Resistance Point 92.36
Last Price 91.61
1st Support Level 90.54
2nd Support Level 89.48
3rd Support Level 88.72

See More

52-Week High 109.58
Fibonacci 61.8% 92.27
Last Price 91.61
Fibonacci 50% 86.93
Fibonacci 38.2% 81.58
52-Week Low 64.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.